AFT Pharmaceuticals Limited (NZE:AFT)

AFT Pharmaceuticals Balance Sheet

Financials in millions NZD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	10.24	11.11	12.04	4.75	7.94
Cash & Short-Term Investments	10.24	11.11	12.04	4.75	7.94
Cash Growth	-7.83%	-7.72%	153.53%	-40.19%	147.43%
Accounts Receivable	58.13	43.2	41.01	39.62	29.87
Receivables	58.13	43.2	41.01	39.62	29.87
Inventory	74.07	48.48	49.06	42.4	33.5
Prepaid Expenses	6.11	5.37	3.22	7.1	6.14
Other Current Assets	-	0.19	0.41	0.74	0.1
Total Current Assets	148.54	108.34	105.73	94.6	77.54
Property, Plant & Equipment	3.36	3.25	3.82	3.37	3.36
Other Intangible Assets	17.58	17.26	14.45	16.17	15.99
Long-Term Deferred Tax Assets	0.8	-	2.25	4.47	8.33
Long-Term Deferred Charges	46.72	40.97	39.01	29.46	22.11
Total Assets	217.01	169.82	165.26	148.06	127.32

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	29.59	25.12	25.33	22.19	12.07
Accrued Expenses	11.89	9.8	11.85	9.57	8.11
Short-Term Debt	11.58	1.08	-	1.46	-
Current Portion of Long-Term Debt	-	-	-	1	4
Current Portion of Leases	0.94	0.73	0.8	0.57	0.54
Current Income Taxes Payable	7.04	2.68	3.8	0.83	0.84
Other Current Liabilities	5.31	3.86	4.29	4.16	3.48
Total Current Liabilities	66.35	43.26	46.07	39.78	29.05
Long-Term Debt	39	25.6	28.2	32.2	33.2
Long-Term Leases	2.59	2.59	3.19	2.82	2.77
Long-Term Deferred Tax Liabilities	-	1.3	-	-	-
Total Liabilities	107.94	72.74	77.46	74.8	65.02

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	78.24	78.24	78.24	78.24	80.77
Retained Earnings	32.38	19.54	9.26	-5.2	-15.85
Comprehensive Income & Other	-0.34	-0.14	0.3	0.23	-2.61
Total Common Equity	110.28	97.64	87.8	73.27	62.31
Minority Interest	-1.21	-0.56	-	-	-
Shareholders' Equity	109.07	97.08	87.8	73.27	62.31
Total Liabilities & Equity	217.01	169.82	165.26	148.06	127.32

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	54.11	30	32.19	38.05	40.51
Net Cash (Debt)	-43.87	-18.89	-20.15	-33.3	-32.57
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.42	-0.18	-0.19	-0.32	-0.31
Filing Date Shares Outstanding	104.87	104.87	104.87	104.87	104.71
Total Common Shares Outstanding	104.87	104.87	104.87	104.87	104.7
Working Capital	82.2	65.09	59.66	54.83	48.49
Book Value Per Share	1.05	0.93	0.84	0.70	0.60
Tangible Book Value	92.7	80.38	73.34	57.1	46.32
Tangible Book Value Per Share	0.88	0.77	0.70	0.54	0.44
Machinery	2.59	2.43	2.15	2.02	2.05

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error